Global Coalition on Aging to Carry Business Voice at IAGG’s 21st World Congress

Three GCOA-Led Symposia to Address Innovations in Skin Health, Elder Caregiving, Alzheimer’s Disease, Financial Services and Technology to Enable Healthy Aging

NEW YORK (July 21, 2017) – The Global Coalition on Aging (GCOA), the leading business voice on aging, will be featured in three symposia at the 21st World Congress of the International Association of Gerontology and Geriatrics (IAGG). In addition, GCOA members – including Bank of America Merrill Lynch, Nestlé Skin Health, and Pfizer – will lead various sessions throughout the weeklong conference.

IAGG’s World Congress, held in a different host country every four years, is among the largest gatherings of aging experts in the world and will bring more than 6,000 experts in aging from across medicine, nursing, social science, finance, and policy, including academics, healthcare professionals and business leaders, to San Francisco, on July 22-27.

“We are thrilled to have the opportunity to join with leaders from our member companies, the World Health Organization, EasyCare Academy, and other cross-sector experts to address some of the most transformational issues related to aging and to share our expertise toward the goal of ensuring more people are able to enjoy the gift of 21st century longevity,” said Michael W. Hodin, CEO of GCOA. “We applaud IAGG and the Gerontological Society of America for their leadership in driving the global dialogue on healthy and active aging.”

Major topics GCOA will address during IAGG include:

  • Alzheimer’s innovation – GCOA’s Dementia Innovation Readiness Index highlights the need for innovation both toward a cure and better care for those living with Alzheimer’s and other dementias. To help advance these goals, a critical step should be for regulatory bodies – and the FDA urgently – to address the regulatory requirement for co-primary endpoints of function and cognition in Alzheimer’s disease. Co-primary end points create a disincentive to Alzheimer’s pharmaceutical innovation and sets Alzheimer’s apart from other therapeutic areas where only one primary endpoint is required.
  • Functional ability – As laid out in the World Health Organization’s Ageing and Health Strategy, maintaining functional ability is a critical factor toward healthy aging.  For example, better monitoring for signs of non-communicable diseases – particularly Alzheimer’s disease – and the conditions of aging, can lead to early detection and diagnosis that map toward healthier lives and better care.
  • Elder caregiving – As the world’s caregiving needs increase, the care continuum opens up to new innovations in elder caregiving, both from the public and private sectors. From home care to remote patient monitoring and from addressing functional ability to improving benefits for elder caregivers in the workplace, new approaches to caring for seniors, particularly keeping care in the home, will be essential for extending quality of life.
  • Skin health – With longer lives comes aging skin, which if addressed across the life course can enhance overall quality of life and lead to healthier longevity.  If our skin must protect us for 100 years or longer, protecting our skin today should not be an afterthought; it is an imperative.

The three GCOA-affiliated symposia include:

Nestlé: Nutrition, Health and Wellness Solutions for Independence, Functional Ability and Wellness as We Grow Older
Monday, July 24, 2017 | 12:30 – 2pm
Moscone West | Room 3024
This session is an industry-supported symposium held in conjunction with IAGG’s 21st World Congress.

Achieving 21st Century Functional Ability Through More Effective Elder Caregiving
Monday, July 24, 2017 | 4 – 5:30pm
Marriott Marquis | Salon 14

The EasyCare Project: A Global Initiative for Healthy Aging Through Person-Centered Assessment and Use of Data to Inform the Development of Policy, Products, and Services
Tuesday, July 25, 2017 | 12:30 – 2pm
Moscone West | Room 3024
This session is an industry-supported symposium held in conjunction with IAGG’s 21st World Congress.

For more details about these sessions, including a list of speakers, please visit the GCOA website.

A full listing of IAGG sessions led by GCOA members follows below:

Workshop: Self-Care Technology for the Aging Population: Why We Need to Invest in Health Tech for the 60+ Consumer*
Saturday, July 22, 2017 | 2 – 6:30pm
Moscone West  | Room 2003 – 2005 *Pre-registration required

Poster: Efficacy of Skin Moisturizer with Advanced Ceramide and Filaggrin Technology in Chinese Elderly 
Sunday, July 23, 2017 | 6:30 – 8:30pm
Moscone West  | West Hall

Symposium: Expanding Perspectives on Vaccine-Preventable Disease in Older Adult Populations 
Monday, July 24, 2017 | 6:30 – 8am
Moscone West  | Room 3020

Symposium: Sleep and Wellness in Aging 
Monday, July 24, 2017 | 12:30 – 2pm
Moscone West  | Room 3020

Symposium: Nestlé: Nutrition, Health and Wellness Solutions for Independence, Functional Ability and Wellness as We Grow Older 
Monday, July 24, 2017 | 12:30 – 2pm
Moscone West  | Room 3024

Symposium: Achieving 21st Century Functional Ability Through More Effective Elder Caregiving
Monday, July 24, 2017 | 4 – 5:30pm
Marriott Marquis  | Salon 14

Symposium: Loss of Vocational Capacity in Senior Professionals 
Monday, July 24, 2017 | 6 – 7:30pm
Moscone West  | Room 3014

Symposium: The EasyCare Project: A Global Initiative for Healthy Aging Through Person-Centered Assessment and Use of Data to Inform the Development of Policy, Products, and Services
Tuesday, July 25, 2017 | 12:30 – 2pm
Moscone West  | Room 3024

Symposium: Emergent Issues in Pneumococcal Disease Among Aging Populations 
Tuesday, July 25, 2017 | 12:30 – 2pm
Moscone West  | Room 3020

Keynote: The Longevity Revolution and the Private Sector – Redefining Work, Leisure, Money, Purpose, and Success 
Wednesday, July 26, 2017 | 10 – 11am
Moscone West  | Room 2009 – 2011

Bank of America Merrill Lynch Exhibit
Ongoing
Moscone West  | Exhibit Hall, Booth #712

Pfizer Exhibit
Ongoing
Moscone West  | Exhibit Hall, Booth #601

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.